Aptima Trichomonas Vaginalis Assay - Panther
Trichomonas Vaginalis Nucleic Acid Amplification Test System. 510(k) K122062, from Gen-Probe, Inc. (San Diego, CA). Product code OUY, class 2.
As of Nov 22, 2026, K122062 is an FDA 510(k) held by Gen-Probe, Inc., substantially equivalent on Jan 9, 2013 after 180 days, with no recalls tied to it in FDA's recall database.
- Review time: 180 days
- Recalls: 0
- Cited as a predicate by: 5 devices
The APTIMA Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the PANTHER System.
- K102911K102911
- Aptima Trichomonas vaginalis AssayK231316 · Hologic, Inc. · Nov 6, 2023
- Aptima Combo 2 Assay (250 test kit) Panther, Aptima Combo 2 Assay (250 test kit) Tigris, Aptima Trichomonas Vaginalis…K220321 · Hologic, Inc. · Jun 3, 2022
- Aptima Combo 2 Assay (Panther) - 250 test kit, Aptima Combo 2 Assay (Tigris) - 250 test kit, Aptima Trichomonas…K200436 · Hologic, Inc. · Mar 23, 2020
- Xpert® TV Assay on the Cepheid GeneXpert Instrument Systems (GeneXpert Dx, GeneXpert Infinity-48, GeneXpert…K151565 · Cepheid · Oct 16, 2015
- AmpliVue Trichomonas AssayK143329 · Quidel Corporation · Mar 17, 2015
- Aptima Trichomonas vaginalis AssayK231316 · Hologic, Inc. · Nov 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 13, 2012
- Review panel
- Immunology
- Regulation
- 21 CFR 866.3860
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files